Cite
MLA Citation
Lee Mozessohn et al.. “Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast–Count Acute Myeloid Leukemia.” JCO oncology practice, vol. 17, no. 4, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100150610606.0x000004